Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
143 employees
ATUM: A biotech service provider leveraging machine learning and GPS technology for optimized bioengineering solutions.
HQ
Founded
2003
Founded with a mission to revolutionize bioengineering, ATUM leverages advanced machine learning and GPS technology to optimize biological systems. The company offers a suite of biotechnology services including codon optimization, recombinant protein production, antibody humanization and engineering, and cell line development. ATUM focuses on providing tailored solutions to life sciences researchers, aiming to accelerate their path to market and enhance the efficiency of their experimental processes.
ATUM's notable affiliations include collaborations with leading research institutions and biotech companies. The company has attracted investment from prominent venture capital firms specializing in life sciences. Key achievements include the successful deployment of their GPS® technology platform, which integrates design of experiments (DoE) with machine learning to deliver optimized bioengineering solutions. Overall, ATUM has made a significant impact by advancing research capabilities and expediting the development of innovative biotechnological applications.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Biotechnology Services
Technology
Machine Learning
Tags
Biotech
Model Types
Professional Services, Platform
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Small Business
Geographic Exposure
Global
When was Atum founded?
Atum was founded in 2003.
Where is Atum's headquarters located?
Atum's headquarters is located in Dublin, IE.
How many employees does Atum have?
Atum has 143 employees as of Feb 4, 2024.
Add Comparison
Current Employees
143
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts